News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Interferon Alpha Can Delay Full Onset Of Type I Diabetes, University of Texas Medical School Study


7/1/2009 9:23:18 AM

EurekAlert! -- HOUSTON – (July 1, 2009) – A low dose of oral interferon alpha shows promise in preserving beta cell function for patients with newly diagnosed type 1 diabetes, or juvenile diabetes, according to researchers at The University of Texas Medical School at Houston.

Read at EurekAlert!

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES